Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02596438 · ClinicalTrials.gov registry record
Thousand Asian American Study
A clinical trial of Hepatitis B, sponsored by University of California, Davis.
- Completed
- Registry status
- 1,076
- Enrollment target
- 1
- Study location
NCT02596438: Completed study of Hepatitis B, sponsored by University of California, Davis.
NCT02596438 is a study of Hepatitis B that has completed, run by University of California, Davis. The registered enrollment target is 1,076 participants, below the 1,595-participant average among 32 other Hepatitis B trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02596438, a study of Hepatitis B, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 1,076 participants
- Enrollment target
- 1
- Study location
Study Summary
The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.
Conditions Studied
Interventions
- OTHER Hepatitis B
Study Locations (1)
California
- University of California, Davis Comprehensive Cancer Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,076 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2017-09-30 |
What the finished NCT02596438 record still lists
NCT02596438 is an observational study that tracks outcomes without assigning an intervention. Its 1,076 participants enrollment target places it among the larger protocols in the corpus, below the 1,595-participant average among 32 other Hepatitis B trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Hepatitis B appearing as the primary indexed condition, and to 1 intervention - of which Hepatitis B is the first listed.
NCT02596438 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02596438 about?
NCT02596438 is a clinical study titled "Thousand Asian American Study". The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.
What is the current status of trial NCT02596438?
This trial is currently completed. The enrollment target is 1,076 participants. The study started on 2012-10-01. Estimated completion is 2017-09-30.
What conditions does trial NCT02596438 study?
This clinical trial studies the following conditions: Hepatitis B.
What interventions are being tested in trial NCT02596438?
The interventions under investigation include: Hepatitis B (OTHER).
Who is sponsoring clinical trial NCT02596438?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02596438 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis B
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02596438's enrollment target sits among peer trials
1,076 6th of 32 higher than 27 of 32 other Hepatitis B trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis B trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Patients With Liver Disease
RECRUITING
-
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RECRUITING · Phase 4
-
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
RECRUITING · Phase 2
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
RECRUITING · Phase 4
-
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI